“The Finance Law, as it stands, is not working. Also for 2007 it confirms the cuts already implemented this year, bringing drug prices below the European average, with peaks of 40% in less. Companies like this are not able to make investment plans”. This is the analysis of Enrica Giorgetti, general manager of Farmindustria, who spoke yesterday at a meeting on the future of multinational drug companies based in Italy, promoted in Rome by the Italian American Pharmaceutical Group and the European Group of Farmindustria.
The situation for pharmaceuticals in our country "is disappointing - he explains - above all because we had proposed a development pact to the government, in which companies put 2 billion euros in investments on the plate over the next three years, with a further commitment to research and an increase in 35% resources". But the executive's response was “a further cut in drug prices. The scenario is very worrying - he underlines - and the risk that companies decide to leave is real. Italy needs to attract new investments and maintain existing ones, which is why the Government must take up the sector's cry of alarm”. From Doctornews 11-13-06
